Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

C4 Therapeutics Stock

Q: How to sell C4 Therapeutics stock?

If you hold private company shares of C4 Therapeutics - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your C4 Therapeutics stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

c4therapeutics.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $74MM

C4 Therapeutics ("C4T") is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Buy or sell C4 Therapeutics stockLearn more about C4 Therapeutics IPO

OverviewFinancingsValuation

Enterprise Value

Access C4 Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like C4 Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Jane Farran Ph.D

Managing Partner

James Bradner MD

Scientific Co-Founder

Andrew Phillips

Chief Executive Officer

Nathanael Gray Ph.D

Co-Founder & Scientific Advisory Board Member

Chris Nasveschuk Ph.D

Vice President, Chemistry

Marc Cohen

Co-Founder & Executive Chairman

Stewart Fisher Ph.D

Chief Scientific Officer

Isabel Chiu Ph.D

Senior Vice President, Strategic Alliances & Product Management

Adam Crystal

Chief Medical Officer

Board Members

Bruce Downey JD

Elena Prokupets Ph.D

Malcolm Salter

Nathanael Gray Ph.D

Ronald Kaiser

Bihua Chen

Cormorant Asset Management

Ken Anderson MD

Miles Stuchin JD

William Scalzulli

The Kraft Family Foundation

Alain Cohen

Cobro Ventures

Jay Eastman Ph.D

EG Capital Group

Marc Cohen

Norman Gretzinger JD

EG Capital Group

C4 Therapeutics stock FAQs

Can you buy C4 Therapeutics stock?

As C4 Therapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like C4 Therapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy C4 Therapeutics stock?

To invest in a private company like C4 Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell C4 Therapeutics stock?

Yes, you may be able to sell your C4 Therapeutics stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell C4 Therapeutics stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your C4 Therapeutics stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is C4 Therapeutics a public company?

No, C4 Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is C4 Therapeutics’ stock price?

C4 Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access C4 Therapeutics’ private market stock price with Forge Data.

What is C4 Therapeutics’ stock ticker symbol?

C4 Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Business Wire 09/23/2019

C4 Therapeutics Announces the Addition of Ryan B. Corcoran, M.D., Ph.D. to the Scientific Advisory Board

Fierce Biotech 03/14/2019

C4 poaches new CMO after signing $900M clinical development deal with Roche

C4 Therapeutics has hired Adam Crystal, M.D., Ph.D., a senior director at the Novartis Institutes for BioMedical Research, to be its new chief medical officer and help carry its targeted protein degraders closer to the clinic.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.